Patents by Inventor Mauris N. DeSilva

Mauris N. DeSilva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
    Publication number: 20170252469
    Abstract: The inventive method relates to a method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expression.
    Type: Application
    Filed: June 26, 2014
    Publication date: September 7, 2017
    Applicant: The United of America as represented by the Secretary of the Navy
    Inventors: Stephen T. Schultz, Mauris N. DeSilva, Georgianna G. Gould
  • Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
    Publication number: 20150374857
    Abstract: The inventive method relates to a method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expression.
    Type: Application
    Filed: June 26, 2014
    Publication date: December 31, 2015
    Inventors: Stephen T. Schultz, Mauris N. DeSilva, Georgianna G. Gould
  • SCAFFOLD FOR ENHANCED NEURAL TISSUE REGENERATION
    Publication number: 20150044259
    Abstract: This application discloses a scaffold for promoting the growth of a nerve in a mammal while minimizing clumping, which comprises a support structure having an elongate opening formed therein and configured for placement around a damaged region of a nerve and a physiologically acceptable matrix composition in said opening, said matrix composition comprising a Poly-D Lysine (PDL) and a peptidoglycan, and Nerve Growth Factor (NGF).
    Type: Application
    Filed: August 8, 2013
    Publication date: February 12, 2015
    Inventor: Mauris N. Desilva
  • NANO-ENCAPSULATED THERAPEUTICS FOR CONTROLLED TREATMENT OF INFECTION AND OTHER DISEASES
    Publication number: 20130089599
    Abstract: This invention relates to a method to provide immediate, direct and controlled time release of an effective amount of therapeutics to a wound site for a prolonged period. The pharmaceutical formulation comprising a plurality of nanoparticles, said nanoparticles encapsulating a therapeutically effective amount of one or more antibacterial agents, and an application of the formulation to an implant before surgery provide for extended release of said antibacterial agents.
    Type: Application
    Filed: June 10, 2012
    Publication date: April 11, 2013
    Applicant: The United States of America as Represented by the Secretary of the Navy
    Inventors: Mauris N. DeSilva, Karen O'Connor, Amer Tiba
  • Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
    Publication number: 20120225015
    Abstract: The inventive method relates to a method for the determination of susceptibility or diagnosis of autism or autism spectrum disorders. Diagnosis or determination of susceptibility determinations are predicated on quantitative analysis of endocannibinoid levels or endocannibinoid receptor expression.
    Type: Application
    Filed: March 3, 2012
    Publication date: September 6, 2012
    Inventors: Stephen T. Schultz, Mauris N. DeSilva, Georgianna G. Gould